A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]